Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers.

Yousef M Al-SarairehFatemah O F O AlshammariAhmed M M YoussefFatima Al-TarawnehSameeh Al-SarayrehGhadeer H AlmuhaisenAnas O SatariJehad Al-ShuneigatHamzeh Mohammad Alrawashdeh

Published in: Breast cancer (Dove Medical Press) (2021)

CYP4ZI may be a potential biomarker or target for evolving new CYP4Z1-targeted treatments.

Keyphrases

poor prognosis
cancer therapy
binding protein
long non coding rna
drug delivery